Type 2 Diabetes

Showing NaN - NaN of 71

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes Trial in Worldwide (Orforglipron, Semaglutide)

Not yet recruiting
  • Type 2 Diabetes
  • Phoenix, Arizona
  • +135 more
Sep 13, 2023

Non-Alcoholic Fatty Liver Disease, Type 2 Diabetes, Obesity Trial in United States (HU6, Placebo)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +3 more
  • Montclair, California
  • +5 more
Jul 31, 2023

Type 2 Diabetes, T2D Trial in Worldwide (LY3209590, Insulin Glargine)

Recruiting
  • Type 2 Diabetes
  • T2D
  • Birmingham, Alabama
  • +71 more
Jan 26, 2023

Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)

Active, not recruiting
  • Type 2 Diabetes
  • Little Rock, Arkansas
  • +129 more
Jan 19, 2023

Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • +2 more
  • Birmingham, Alabama
  • +74 more
Apr 18, 2022

Type 2 Diabetes, Comparative Effectiveness of Glycemia-lowering Medications Trial in United States (Sulfonylurea (glimepiride),

Completed
  • Type 2 Diabetes
  • Comparative Effectiveness of Glycemia-lowering Medications
  • Sulfonylurea (glimepiride)
  • +3 more
  • Birmingham, Alabama
  • +35 more
Apr 13, 2022

Type 2 Diabetes Trial in Worldwide (Mylan's insulin glargine, LantusĀ®)

Completed
  • Type 2 Diabetes
  • Chandler, Arizona
  • +119 more
Mar 1, 2022

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Dapagliflozin )

Completed
  • Type 2 Diabetes
  • New Haven, Connecticut
  • +41 more
Jan 28, 2022

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Semaglutide)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +126 more
Jan 21, 2022

Type 2 Diabetes Trial in Australia, China, United States (INS068 injection, Insulin Degludec)

Active, not recruiting
  • Type 2 Diabetes
  • INS068 injection
  • Insulin Degludec
  • Huntington Park, California
  • +32 more
Jan 27, 2022

Type 2 Diabetes Trial in United States (BT-001, Physician-guided Standard of Care for type 2 diabetes)

Active, not recruiting
  • Type 2 Diabetes
  • BT-001
  • Physician-guided Standard of Care for type 2 diabetes
  • San Francisco, California
  • +5 more
Jan 13, 2022

Type 2 Diabetes Trial in Miami, Atlanta, New York (Liraglutide + OADs, Glargine + OADs)

Completed
  • Type 2 Diabetes
  • Liraglutide + OADs
  • Glargine + OADs
  • Miami, Florida
  • +4 more
Oct 5, 2021

Coronavirus Infection, Type 2 Diabetes Trial in Miami (Linagliptin, Insulin regimen)

Withdrawn
  • Coronavirus Infection
  • Type 2 Diabetes
  • Miami, Florida
    University of Miami
Jun 7, 2021

Type 2 Diabetes Trial in United States (Tirzepatide, Placebo)

Completed
  • Type 2 Diabetes
  • Fresno, California
  • +12 more
Apr 28, 2021

Type 2 Diabetes Trial in United States (Rivoglitazone, Pioglitazone, Placebo)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +73 more
May 6, 2021

Type 2 Diabetes Trial in Miami (Dapagliflozin, Metformin, Placebo)

Completed
  • Type 2 Diabetes
  • Miami, Florida
    University of Miami
Jan 27, 2021

Type 2 Diabetes Trial in Worldwide (Placebo, Exenatide)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +52 more
Nov 6, 2020

Type 2 Diabetes Trial in United States (Mesenchymal Precursor Cells (MPCs))

Completed
  • Type 2 Diabetes
  • Mesenchymal Precursor Cells (MPCs)
  • Garden Grove, California
  • +17 more
Jun 1, 2020

Type 2 Diabetes Trial in Worldwide (Dulaglutide, Placebo)

Completed
  • Type 2 Diabetes
  • Glendale, California
  • +65 more
Sep 5, 2019

Type 2 Diabetes, Chronic Kidney Disease Trial in Worldwide (Dulaglutide, Insulin glargine, Insulin lispro)

Completed
  • Type 2 Diabetes
  • Chronic Kidney Disease
  • Montgomery, Alabama
  • +88 more
Sep 6, 2019

Type 2 Diabetes Trial in United States (LY2189102, Placebo)

Completed
  • Type 2 Diabetes
  • Mobile, Alabama
  • +17 more
Sep 6, 2019

Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

Completed
  • Cardiovascular Disease
  • +4 more
  • Lorcaserin hydrochloride
  • Placebo
  • Alexander City, Alabama
  • +498 more
Jun 27, 2019

Type 2 Diabetes, Overweight, Obesity Trial in Miami (Liraglutide, Metformin)

Completed
  • Type 2 Diabetes
  • +2 more
  • Miami, Florida
    University of Miami
Jun 4, 2019

Type 2 Diabetes Trial in United States (MEDI-4166, Placebo)

Completed
  • Type 2 Diabetes
  • MEDI-4166
  • Placebo
  • Anniston, Alabama
  • +10 more
Mar 12, 2019

Type 2 Diabetes Trial in United States (ITCA 650 (exenatide in DUROS))

Terminated
  • Type 2 Diabetes
  • ITCA 650 (exenatide in DUROS)
  • Birmingham, Alabama
  • +50 more
Mar 4, 2019